highly significantP < 0.001
The rate of patients censored for ERPI-good was 96.9% and 79.6% for ERPI-poor, with a highly significant difference ( χ 2 = 40.037, P < 0.001) (Figure 1 B, supplementary Table S4, available at Annals of Oncology online ).
The rate of patients censored for ERPI-good was 96.9% and 79.6% for ERPI-poor, with a highly significant difference ( χ 2 = 40.037, P < 0.001) (Figure 1 B, supplementary Table S4, available at Annals of Oncology online ).